Similar beneficial effects of JQ1 were observed in human and mouse models of Rett syndrome (RTT), caused by loss of function of the X-linked gene encoding MeCP2 (methyl-CpG binding protein 2). This evidence concerns the gene MECP2 and atypical Rett syndrome.